³Ô¹ÏÍøÕ¾

Latest ovarian cancer News | Page 2

Brisbane breast cancer Fun Run is sold out and bigger than ever
Mater People ride to raise funds for cancer
Doctors remove mum’s 5kg tumour as she delivers baby
Research discovery could improve treatment for ovarian cancer
Competition opens to elevate early-stage medtech pitches
NIH grant explores repetitive DNA sequences
Backpacking adventure becomes cancer journey for Tora, 24
Call for nominations for the Jeannie Ferris Award to recognise outstanding contributions to improving equity of cancer outcomes
Investing In Victoria’s Cancer Research
Sowing seeds for better cancer outcomes
Ovarian cancer champion urging women to know symptoms
Enhertu granted Priority Review in the US for patients with metastatic HER2-positive solid tumours
Revolution in hysterectomy surgery comes to Springfield
Expanded PBS listings make vital treatments more affordable
Mothers need more “exclusive breastfeeding” support
Showing support for our LGBTIQ+ community this PrideFEST
Mater Researcher shares in $1.8 million to fight one of Australia’s deadliest cancers
Population DNA screening for multiple diseases would save lives and be cost effective: study
Leading innovation and advancement in pathology, for over 104 years
Jessica’s story, ovarian cancer at young age
Predicting cancer patient response to drugs that block DNA repair
From Qld to the Big Apple: QPS pound the pavement at NYC Marathon
Researcher’s work on ‘kiss of death’ protein gets industry accolades
Clinical trials give Queensland breast cancer patients hope
Imugene announces phase 1 clinical trial opens with onCARlytics CD19 virus technology
Anna Boltong Appointed As Ovarian Cancer Australia CEO
Important workers compensation reforms supporting fire-fighters pass Parliament
WINNERS: 2023 Nike Melbourne Marathon Festival
Manchester scientists investigate how to stop a more aggressive form of breast cancer spreading
Starpharma announces the presentation of DEP irinotecan combination data
Compound d16 reduces tumor growth and overcomes therapeutic resistance in mutant p53-bearing cancers
Combination of personalized cancer vaccine and adoptive T cell therapy benefits patients with advanced ovarian cancer
Tests that diagnose diseases are less reliable than you’d expect. Here’s why
Progressing nation-leading reforms for our firefighters
Mater Research’s Future Leaders Celebrated at Annual Symposium
Leading the way in health and safety for Tasmania’s fire-fighters
6 things to know about ovarian cancer
Law reform agenda strong as Government prepares for Parliament’s return
Ovarian cancer patient plans wedding in hospital
Melbourne team on the verge of a more accurate test for ovarian cancer
Can the body’s signalling protein be harnessed to stop ovarian cancer?
Greens introduce bill to expand presumptive cancer scheme for Victorian firefighters
Enhertu demonstrated clinically meaningful progression-free survival and overall survival across multiple HER2-expressing advanced solid tumours in DESTINY-PanTumor02 Phase II trial
Mater revolutionises hysterectomy surgery for women
Early-Stage Innovation Forum opens
Study improves accuracy of predictive breast cancer genetic test for Ashkenazi Jewish women
Sculpture soars in memory of Maureen Nathan
Acceptance is a big thing – you’ve got to accept what’s happening to you to move forward  Â